QuickView for nuclear pore complex assembly (biogroup)

1. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
2. L1000 CMAP - Skeletal muscle SKL.C cells treated with small molecule perturbagens
3. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
4. L1000 CMAP - Melanoma A375 cells with CRISPR-targeted gene knockouts
5. Keratinocytes, COL7A1 mutant from recessive dystrophic epidermolysis bullosa (RDEB) patients

1. Regulation and coordination of nuclear envelope and nuclear pore complex assembly.
2. Lumenal interactions in nuclear pore complex assembly and stability.
3. Dimerization and direct membrane interaction of Nup53 contribute to nuclear pore complex assembly.
4. NSF- and SNARE-mediated membrane fusion is required for nuclear envelope formation and completion of…
5. The karyopherin Kap95 regulates nuclear pore complex assembly into intact nuclear envelopes in vivo.

There were no clinical trials for nuclear pore complex assembly